ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/A-lifetime-in-Paradise

Body Abstract:Although the global burden of cancer is not known with precision, it is certain that it has doubled over the last 25 years and is set to double again before 2030.

Date: 26 Sep 2014
Presenter: Peter Boyle
Resources: Abstract
Topic: Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...and-its-implications-for-cancer-surveillance

Body Abstract:There is evidence for germline genetic variation predisposing to increased cancer risk. The data suggest that there are common risk variants each conferring a slightly increased risk (but...

Date: 27 Sep 2014
Presenter: Ros Eeles
Resources: Abstract
Topics: Cancer Aetiology, Epidemiology, Prevention, Genetic Syndromes related Cancers

http://oncologypro.esmo.org/Meeting-Resourc...-A-single-institution-observational-analysis

AimNSCLC in NS often harbors proto-oncogene aberrations, showing enrichment for targetable alterations compared to unselected populations. Objectives of this study were to define the proportions of the...

Date: 27 Sep 2014
Presenter: Chiara Bennati
Resources: Abstract
Topics: Non-Small-Cell Lung Cancer, Metastatic, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...mutations-a-review-of-incidence-and-outcomes

AimPatients (pts) with advanced NSCLC and BM have a poor prognosis. However, there are reports of improved survival of pts with epidermal growth factor receptor (EGFR) mutation positive NSCLC who develop BM.

Date: 27 Sep 2014
Presenter: Jennifer King
Resources: Abstract
Topics: Non-Small-Cell Lung Cancer, Metastatic, Cancer Aetiology, Epidemiology, Prevention, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...Ovarian-cancer-survival-in-Estonia-1995-2009

AimOvarian cancer (OC) has the highest mortality rates among gynecological cancers. Cytoreductive surgery and adjuvant chemotherapy have been the standard of care for more than three decades.

Date: 27 Sep 2014
Presenter: Kristiina Ojamaa
Resources: Abstract
Topics: Ovarian Cancer, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...f-vulval-cancer-in-Kazakhstan-and-Kyrgyzstan

AimTo study vulval cancer (VC) incidence, age-specific rate, geographical, and ethnic differences in the Kazakh and Kyrgyz Republics.MethodsThere were 852 registered with new diagnosis of VC in Kazakhstan...

Date: 27 Sep 2014
Presenter: Emil Makimbetov
Resources: Abstract
Topics: Vulvar and Vaginal Cancers, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...pesvirus-infection-in-vulvar-cancer-patients

AimThe purpose of the study was to detect frequency of Human papillomavirus infection (HPV) and herpes viruses in vulvar cancer patients.MethodsSamples of formalin-fixed paraffin embedded tumor tissues...

Date: 27 Sep 2014
Presenter: Galina Nerodo
Resources: Abstract
Topics: Vulvar and Vaginal Cancers, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...cteristics-of-a-Danish-cohort-of-83-patients

AimAppendiceal goblet cell carcinoids (GCCs) exhibit neuroendocrine and adenocarcinoma features. Demographic, pathological features, prognostic markers, treatment and survival are presented.

Date: 27 Sep 2014
Presenter: Ingrid Holst Olsen
Resources: Abstract
Topics: Neuroendocrine Cancers, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...-PC-patients-pts-US-claims-database-analysis

AimNewly diagnosed (dx) M1 PC pts have a poor prognosis (median survival 3.7 yrs [Hussain, NEJM 2013]), and their characterization is mainly based on clinical trial data.

Date: 27 Sep 2014
Presenter: Thomas Flaig
Resources: Abstract
Topics: Prostate Cancer, Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...udy-to-examine-patterns-of-care-and-outcomes

BackgroundThe treatment landscape for men with later-stage prostate cancer has changed dramatically over the past several years due to an increase in the understanding of the natural history of the...

Date: 27 Sep 2014
Presenter: Maria De Santis
Resources: Abstract
Topics: Prostate Cancer, Cancer Aetiology, Epidemiology, Prevention